Literature DB >> 24223865

A novel scoring system to measure radiographic abnormalities and related spirometric values in cured pulmonary tuberculosis.

Renata Báez-Saldaña1, Yesenia López-Arteaga, Alma Bizarrón-Muro, Elizabeth Ferreira-Guerrero, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sánchez, Luis Pablo Cruz-Hervert, Norma Mongua-Rodríguez, Lourdes García-García.   

Abstract

BACKGROUND: Despite chemotherapy, patients with cured pulmonary tuberculosis may result in lung functional impairment.
OBJECTIVE: To evaluate a novel scoring system based on the degree of radiographic abnormalities and related spirometric values in patients with cured pulmonary tuberculosis.
METHODS: One hundred and twenty seven patients with cured pulmonary tuberculosis were prospectively enrolled in a referral hospital specializing in respiratory diseases. Spirometry was performed and the extent of radiographic abnormalities was evaluated twice by each of two readers to generate a novel quantitative score. Scoring reproducibility was analyzed by the intra-class correlation coefficient (ICC) and the Bland-Altman method. Multiple linear regression models were performed to assess the association of the extent of radiographic abnormalities with spirometric values.
RESULTS: The intra-observer agreement for scoring of radiographic abnormalities (SRA) showed an ICC of 0.81 (CI:95%, 0.67-0.95) and 0.78 (CI:95%, 0.65-0.92), for reader 1 and 2, respectively. Inter-observer reproducibility for the first measurement was 0.83 (CI:95%, 0.71-0.95), and for the second measurement was 0.74 (CI:95%, 0.58-0.90). The Bland-Altman analysis of the intra-observer agreement showed a mean bias of 0.87% and -0.55% and an inter-observer agreement of -0.35% and -1.78%, indicating a minor average systematic variability. After adjustment for age, gender, height, smoking status, pack-years of smoking, and degree of dyspnea, the scoring degree of radiographic abnormalities was significantly and negatively associated with absolute and percent predicted values of FVC: -0.07 (CI:95%, -0.01 to -0.04); -2.48 (CI:95%, -3.45 to -1.50); and FEV1 -0.07 (CI:95%, -0.10 to -0.05); -2.92 (CI:95%, -3.87 to -1.97) respectively, in the patients studied.
CONCLUSION: The extent of radiographic abnormalities, as evaluated through our novel scoring system, was inversely associated with spirometric values, and exhibited good reliability and reproducibility. As intra-observer and inter-observer agreement of the SRA varied from good to excellent, the use of SRA in this setting appears acceptable.

Entities:  

Mesh:

Year:  2013        PMID: 24223865      PMCID: PMC3815252          DOI: 10.1371/journal.pone.0078926

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  23 in total

1.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

2.  Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function.

Authors:  R Long; B Maycher; A Dhar; J Manfreda; E Hershfield; N Anthonisen
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis.

Authors:  Mauricio Vecino; Jotam G Pasipanodya; Philip Slocum; Sejong Bae; Guadalupe Munguia; Thaddeus Miller; Michel Fernandez; Gerry Drewyer; Stephen E Weis
Journal:  J Infect Public Health       Date:  2011-10-20       Impact factor: 3.718

5.  Epidemiology Standardization Project (American Thoracic Society).

Authors:  B G Ferris
Journal:  Am Rev Respir Dis       Date:  1978-12

6.  Spirometry in the Lung Health Study. 1. Methods and quality control.

Authors:  P L Enright; L R Johnson; J E Connett; H Voelker; A S Buist
Journal:  Am Rev Respir Dis       Date:  1991-06

7.  Chronic obstructive airways disease following treated pulmonary tuberculosis.

Authors:  P A Willcox; A D Ferguson
Journal:  Respir Med       Date:  1989-05       Impact factor: 3.415

8.  Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment.

Authors:  E Hnizdo; T Singh; G Churchyard
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

9.  Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.

Authors:  M L Plit; R Anderson; C E Van Rensburg; L Page-Shipp; J A Blott; J L Fresen; C Feldman
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

Review 10.  Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis.

Authors:  Rafael L Perez; Carlos A Rivera-Marrero; Jesse Roman
Journal:  Semin Respir Infect       Date:  2003-03
View more
  15 in total

1.  Structural and functional pulmonary impairment in treated cases of pulmonary tuberculosis: a cross-sectional study.

Authors:  Neeraj Sharma; Safia Ahmed
Journal:  Med J Armed Forces India       Date:  2020-08-15

2.  Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.

Authors:  Jamilah Meghji; Maia Lesosky; Elizabeth Joekes; Peter Banda; Jamie Rylance; Stephen Gordon; Joseph Jacob; Harmien Zonderland; Peter MacPherson; Elizabeth L Corbett; Kevin Mortimer; Stephen Bertel Squire
Journal:  Thorax       Date:  2020-02-26       Impact factor: 9.139

3.  Sex-Dependent Differential Expression of Lipidic Mediators Associated with Inflammation Resolution in Patients with Pulmonary Tuberculosis.

Authors:  Claudia Carranza; Laura Elena Carreto-Binaghi; Silvia Guzmán-Beltrán; Marcela Muñoz-Torrico; Martha Torres; Yolanda González; Esmeralda Juárez
Journal:  Biomolecules       Date:  2022-03-24

Review 4.  A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.

Authors:  Jamilah Meghji; Hope Simpson; S Bertel Squire; Kevin Mortimer
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

Review 5.  Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

Authors:  Marcela Muñoz-Torrico; Adrian Rendon; Rosella Centis; Lia D'Ambrosio; Zhenia Fuentes; Carlos Torres-Duque; Fernanda Mello; Margareth Dalcolmo; Rogelio Pérez-Padilla; Antonio Spanevello; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

Review 6.  The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy.

Authors:  Cari Stek; Brian Allwood; Naomi F Walker; Robert J Wilkinson; Lutgarde Lynen; Graeme Meintjes
Journal:  Front Microbiol       Date:  2018-10-30       Impact factor: 5.640

7.  A lung image reconstruction from computed radiography images as a tool to tuberculosis treatment control.

Authors:  Marcela de Oliveira; Sergio Barbosa Duarte; Guilherme Giacomini; Paulo Câmara Marques Pereira; Lenice do Rosário de Souza; José Ricardo de Arruda Miranda; Diana Rodrigues de Pina
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-02-14

8.  A Novel Reading Scheme for Assessing the Extent of Radiographic Abnormalities and Its Association with Disease Severity in Sputum Smear-Positive Tuberculosis: An Observational Study in Hyderabad/India.

Authors:  Zarko Grozdanovic; Luis C Berrocal Almanza; Surabhi Goyal; Abid Hussain; Tilman E Klassert; Dominik Driesch; Viktoriya Tokaryeva; Yvonne Yi-Na Löschmann; Gadamm Sumanlatha; Niyaz Ahmed; Vijayalakshmi Valluri; Ralf R Schumann; Birgit Lala; Hortense Slevogt
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Authors:  Jamie Rylance; Grace Mchugh; John Metcalfe; Hilda Mujuru; Kusum Nathoo; Stephanie Wilmore; Sarah Rowland-Jones; Edith Majonga; Katharina Kranzer; Rashida A Ferrand
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

Review 10.  Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.

Authors:  Caleb N Muefong; Jayne S Sutherland
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.